Skip to main content
BMC Genomics logoLink to BMC Genomics
. 2017 Jun 8;18:451. doi: 10.1186/s12864-017-3835-y

Label-free quantitative proteomics of Corynebacterium pseudotuberculosis isolates reveals differences between Biovars ovis and equi strains

Wanderson M Silva 1,5,6, Edson L Folador 3, Siomar C Soares 1,8, Gustavo H M F Souza 4, Agenor V Santos 2, Cassiana S Sousa 1, Henrique Figueiredo 7, Anderson Miyoshi 1, Yves Le Loir 5,6, Artur Silva 2, Vasco Azevedo 1,
PMCID: PMC5463331  PMID: 28595597

Background

Corynebacterium pseudotuberculosis is a Gram-positive facultative intracellular pathogen of the Corynebacterium, Mycobacterium, Nocardia, and Rhodococcus (CMNR) group. The CMNR group of pathogens has high G + C content in their genomes and shows a specific cell wall organization composed of peptidoglycan, arabinogalactan, and mycolic acids [1]. C. pseudotuberculosis is subdivided into two biovars: (i) C. pseudotuberculosis biovar ovis (nitrate negative) which is the etiologic agent of caseous lymphadenitis in small ruminants [2] and mastitis in dairy cattle [3] and (ii) C. pseudotuberculosis biovar equi (nitrate positive) that causes ulcerative lymphangitis and abscesses in internal organs of equines [4] and oedematous skin disease in buffalos [5]. C. pseudotuberculosis infection is reported worldwide and causes significant economic losses by affecting wool, meat, and milk production [69].

Various studies at genome level have been carried out by our research group in order to explore the molecular basis of specific and shared factors among different strains of C. pseudotuberculosis that could contribute to such biovar specific pathogenicity. Our studies on whole-genome sequencing and analysis of several C. pseudotuberculosis strains belonging to biovar ovis and equi, isolated from different hosts showed an average genome size of approximately 2,3 Mb, a core-genome having approximately 1504 genes across several C. pseudotuberculosis species, and accessory genomes of biovar equi and ovis composed of 95 and 314 genes, respectively [1012]. According with pan-genome analysis, C. pseudotuberculosis biovar ovis presented a more clonal-like behavior, than the C. pseudotuberculosis biovar equi. In addition, in this in silico study was observed a variability most interesting related to pilus genes, where biovar ovis strain presented high similarity, while, biovar equi strains have a great variability, suggesting that this variability could influence in the adhesion and invasion cellular of each biovar [10].

Apart from the structural genome informatics studies of C. pseudotuberculosis, some proteomic studies were conducted to explore the functional genome of this pathogen [1319]. However, all these proteomic studies were performed using only strains belonging to biovar ovis. Until the present time, no proteomic studies were performed between biovar equi strains or between biovar ovis and biovar equi strains. Therefore, to provide insights on shared and exclusive proteins among biovar ovis and biovar equi strains and to complement the previous studies on functional and structural genomics of C. pseudotuberculosis biovars, using LC-MSE approach [13, 18] this study reports for the first time a comparative proteomic analysis of two C. pseudotuberculosis strains, 1002_ovis and 258_equi, isolated from caprine (Brazil) and equine (Belgium), respectively. Our proteomic dataset promoted the validations of previous work in silico of C. pseudotuberculosis; in addition, the qualitative and quantitative differences in the proteins identified in this present work have potential to help understand the factors that might contribute for pathogenic process of biovar ovis and equi strains.

Methods

Bacterial strain and growth condition

C. pseudotuberculosis biovar ovis 1002, isolated from a goat in Brazil, and C. pseudotuberculosis biovar equi 258, isolated from a horse in Belgium, were maintained in brain–heart infusion broth or agar (1.5%) (BHI-HiMedia Laboratories Pvt. Ltd., India) at 37 °C. For proteomic analysis, overnight cultures (three biological replicate to each strain) in BHI were inoculated with a 1:100 dilution in fresh BHI at 37 °C and cells were harvested during the exponential growth at DO600 = 0.8 (Additional file 1: Figure S1).

Protein extraction and preparation of whole bacterial lysates for LC-MS/MS

After bacterial growth, the protein extraction was performed according to Silva et al. [18]. The cultures were centrifuged at 4000 x g at 4 °C for 20 min. The cell pellets were washed in phosphate buffered saline (PBS) and then resuspended in 1 mL of lysis buffer (7 M Urea, 2 M Thiourea, CHAPS 4% and 1 M DTT) and 10 μL of Protease Inhibitor Mix (GE Healthcare, Piscataway, NJ, USA) was added. The cells were broken by sonication at 5 × 1 min cycles on ice and the lysates were centrifuged at 14,000 x g for 30 min at 4 °C. Subsequently, samples were concentrated and lysis buffer was replaced by 50 mM ammonium bicarbonate at pH 8.0 using a 10 kDa ultra-filtration device (Millipore, Ireland). All centrifugation steps were performed at room temperature. Finally the protein concentration was determined by Bradford method [20]. A total of 50 μg proteins from each biological replicate of 1002_ovis and 258_equi were denatured by using RapiGEST SF [(0.1%) (Waters, Milford, CA, USA)] at 60 °C for 15 min, reduced with DTT [(10 mM) (GE Healthcare)], and alkylated with iodoacetamide [(10 mM) (GE Healthcare)]. For enzymatic digestion, trypsin [(0.5 μg/μL) (Promega, Sequencing Grade Modified Trypsin, Madison, WI, USA)] was added and placed in a thermomixer at 37 °C overnight. The digestion process was stopped by the addition of 10 μL of 5% TFA (Sigma-Aldrich, St. Louis, Missouri, USA) and glycogen phosphorilase (Sigma-Aldrich) was added to the digests to give 20 fmol.uL−1 as an internal standard for scouting normalization prior to each replicate injection into label-free quantitation [21].

LC-HDMSE analysis and data processing

Qualitative and quantitative analysis were performed using 2D RPxRP (two-dimensional reversed phase) nanoUPLC-MS (Nano Ultra Performance Liquid Chromatography Mass Spectrometry) approach with multiplexed Nano Electrospray High Definition Mass Spectrometry (nanoESI-HDMSE). To ensure that all samples were injected with the same amount into the columns and to ensure standardized molar values across all conditions, stoichiometric measurements based on scouting runs of the integrated total ion account (TIC) were performed prior to analysis. The experiments were conducted using both a 1 h reversed phase gradient from 7% to 40% (v/v) acetonitrile (0.1% v/v formic acid) and a 500 nL.min−1 on a 2D nanoACQUITY UPLC technology system [22]. A nanoACQUITY UPLC HSS (High Strength Silica) T3 1.8 μm, 75 μm × 15 cm column (pH 3) was used in conjunction with a reverse phase (RP) XBridge BEH130 C18 5 μm 300 μm × 50 mm nanoflow column (pH 10). Typical on-column sample loads were 250 ng of total protein digests for each 5 fractions (250 ng/fraction/load). For all measurements, the mass spectrometer was operated in the resolution mode with a typical m/z resolving power of at least 35,000 FMHW and an ion mobility cell filled with nitrogen gas and a cross-section resolving power at least 40 Ω/ΔΩ. All analyses were performed using nano-electrospray ionization in the positive ion mode nanoESI (+) and a NanoLockSpray (Waters, Manchester, UK) ionization source.

The lock mass channel was sampled every 30 s. The mass spectrometer was calibrated with a MS/MS spectrum of [Glu1]-Fibrinopeptide B human (Glu-Fib) solution (100 fmol.uL−1) delivered through the reference sprayer of the NanoLockSpray source.The doubly- charged ion ([M + 2H]2+ = 785.8426) was used for initial single-point calibration and MS/MS fragment ions of Glu-Fib were used to obtain the final instrument calibration. Multiplexed data-independent (DIA) scanning with added specificity and selectivity of a non-linear ‘T-wave’ ion mobility (HDMSE) experiments were performed with a Synapt G2-S HDMS mass spectrometer (Waters), which was automatically planned to switch between standard MS (3 eV) and elevated collision energies HDMSE (19–45 eV) applied to the transfer ‘T-wave’ CID (collision-induced dissociation) cell with argon gas. The trap collision cell was adjusted for 1 eV, using a mili-seconds scan time previously adjusted based on the linear velocity of the chromatography peak delivered through nanoACQUITY UPLC to get a minimum of 20 scan points for each single peak, both in low energy and at high-energy transmission at an orthogonal acceleration time-of-flight (oa-TOF) from m/z 50 to 2000. The RF offset (MS profile) was adjusted is such a way that the nanoUPLC-HDMSE data are effectively acquired from m/z 400 to 2000, which ensured that any masses observed in the high energy spectra with less than m/z 400 arise from dissociations in the collision cell.

Database searching and quantification

Following the identification of proteins, the quantitative data were packaged using dedicated algorithms [23, 24] and searching against a database with default parameters to account for ions [25]. The databases used were reversed “on-the fly” during the database queries and appended to the original database to assess the false positive rate (FDR) during identification. For proper spectra processing and database searching conditions, the Protein Lynx Global Server v.2.5.2 (PLGS) with IdentityE and ExpressionE informatics v.2.5.2 (Waters) were used. UniProtKB (release 2013_01) with manually reviewed annotations was used, and the search conditions were based on taxonomy (Corynebacterium pseudotuberculosis). We have utilized a database from genome annotation of 1002_ovis CP001809.2 version and 258_equi CP003540.2 version. These databases were randomized within PLGS v.2.5.2 for generate a concatenated database from both genomes. Thus, the measured MS/MS spectra from proteomic datasets of 1002_ovis and 258_equi were searched against this concatenated database. The maximum allowed missed cleavages by trypsin were up to one, and variable modifications by carbamidomethyl (C), acetyl N-terminal, phosphoryl (STY) and oxidation (M) were allowed and peptide mass tolerance value of 10 ppm was used [26]. Peptides as source fragments, peptides with a charge state of at least [M + 2H]2+ and the absence of decoys were the factors we considered to increase the data quality. The collected proteins were organized by the PLGS ExpressionE tool algorithm into a statistically significant list that corresponded to higher or lower regulation ratios among the different groups. For protein quantitation, the PLGS v2.5.2 software was used with the IdentityE algorithm using the Hi3 methodology. The search threshold to accept each spectrum was the default value in the program with a false discovery rate value of 4%. The quantitative values were averaged over all samples, and the standard deviations at p < 0.05 were determined using the Expression software. Only proteins with a differential expression log2 ratio between the two conditions greater than or equal to 1.2 were considered [26].

Bioinformatics analysis

The identified proteins in 1002_ovis and 258_equi were subjected to the bioinformatics analysis using the various prediction tools. SurfG+ v1.0 [27] was used to predict sub-cellular localization, SignalP 4.1.0 server [28] to predict the presence of N-terminal signal peptides for secretory proteins, SecretomeP 2.0 server [29] to identify exported proteins from non-classical systems (positive prediction score greater than to 0.5), LipoP server [30] to determine lipoproteins, Blast2GO [31] and COG database [32] were used for functional annotations. The protein-protein interaction network was generated using Cytoscape version 2.8.3 [33] with a spring-embedded layout.

Results and discussion

Characterization of the proteome of C. pseudotuberculosis biovar ovis and equi

In this study, we applied the 2D nanoUPLC-HDMSE approach to characterize the proteome of the strains 1002_ovis and 258_equi. Both strains were grown in BHI media, subsequently proteins were extracted and digested in solution, and then the peptides were analyzed by LC/MSE. Our proteomic analysis identified a total of 1227 non-redundant proteins in 1002_ovis (Additional file 2: Table S1 and Additional file 3: Table S2) and 1218 in 258_equi (Additional file 2: Table S1 and Additional file 4: Table S3) (Fig. 1a). The information about sequence coverage and a number of identified peptides for each protein sequence identified, as well as the information about the native peptide are available at Additional file 5: Table S4 and Additional file 6: Table S5. Altogether from the proteome of these two biovars, we identified a total of 1323 different proteins of C. pseudotuberculosis with high confidence (Fig. 1a) and characterized approximately 58% of the predicted proteome of 1002_ovis [11] (Fig. 1b). In the case of 258_equi, we characterized approximately 57% of the predicted proteome [12] (Fig. 1b). The proteins identified in both proteomes were analyzed by SurfG+ tool [27] to predict the subcellular localization into four categories: cytoplasmic (CYT), membrane (MEM), potentially surface-exposed (PSE) and secreted (SEC) (Fig. 1c). Further, we identified 83% (43 proteins) of the lipoproteins predicted in 1002_ovis and 79% (41 proteins) in 258_equi. Considering proteins with LPxTG motif which are involved in covalent linkage with peptidoglycan, we identified 6 proteins in 1002_ovis and 4 proteins in 258_equi that correspond to approximately 38% and 34% of the LPxTG proteins predicted in each strain, respectively.

Fig. 1.

Fig. 1

Characterization of the proteome of C. pseudotuberculosis and correlation with in silico data. a Distribution of the proteins identified in the proteome of 1002_ovis and 258_equi, represented by Venn diagram. b Correlation of the proteomic results with in silico data of the genomes of 1002_ovis and 258_equi. c Subcellular localization of the identified proteins and correlation with the in silico predicted proteome. CYT, cytoplasmic; MEM, membrane; PSE, potentially surface-exposed and SEC, secreted

The biovar equi and biovar ovis core proteome

The core-proteome, between 258_equi and 1002_ovis is composed of 1122 proteins (Fig. 1) (Additional file 2: Table S1). Interestingly, when correlated these 1122 proteins with in silico data of the C. pseudotuberculosis core-genome [10], we observed that 86% (960 proteins) of the Open Reading Frame (ORF) that encodes these proteins are part of the core-genome (Additional file 2: Table S1), what represents approximately 64% of the predicted core-genome of this pathogen. In addition, these data show a set of proteins involved in different cellular processes which could be necessary for the free living of C. pseudotuberculosis. The other 14% (262 proteins) of the proteins that constitute the core-proteome are shared by at least one of the 15 strains used in the core-genome study. According to Gene Ontology analysis [31, 32], the 1122 proteins were classified into four important functional groups: (i) metabolism, (ii) information storage and processing, (iii) cellular processes and signaling, and (iv) poorly characterized (Fig. 2a). As observed in the study of C. pseudotuberculosis [10] core genome in the categories “metabolism” and “information storage and processing” were detected a large number of proteins.

Fig. 2.

Fig. 2

Representative results of the core-proteome 1002_ovis and 258_equi. a Functional distribution of the proteins identified in the core-proteome. b Volcano plot generated by differentially expressed proteins, log2 ratio of 258_equi/1002_ovis. c Biological processes differential between 258_equi and 1002_ovis

The label-free quantification was applied to evaluate the relative abundance of the core-proteome of 258_equi and 1002_ovis. The ProteinLynx Global Server (PLGS) v2.5.2 software with ExpressionE algorithm tool was used to identify proteins with p ≤ 0.05 (Additional file 2: Table S1). Among these proteins, 120 proteins between 258_equi and 1002_ovis showed difference in level of abundance (log2 ratios equal or greater than a factor of 1.2) [26] (Table 1). In this group of proteins that have presented different abundance level (258_equi:1002_ovis), 49 proteins were more abundant and 71 less abundant (Table 1). To visualize this differential distribution of the core-proteome a volcano plot of the log2 ratio of 258_equi/1002_ovis versus Log (e) Variance was generated (Fig. 2b). Interestingly, the Phospholipase D (Pld), the major virulence factor of C. pseudotuberculosis, was more abundant in 258_equi, than in 1002_ovis (Table 1). The Pld have an important play role in the pathogenic process of C. pseudotuberculosis, due to the sphingomyelinase activity of the Pld, this exotoxin increases vascular permeability through the exchange of polar groups attached to membrane-bound lipids and helps the bacteria in spread inside the host [34, 35]. In addition, this exotoxin is able to reduce the viability of both macrophages and neutrophils [34, 36]. In comparative proteomic studies between 1002_ovis and C231_ovis exoproteome, Pld was detected only in the C231_ovis supernatant [13, 15, 16]. A study performed with pld mutant strains presented decreased virulence [37]. Thus, in relation to 258_equi, 1002_ovis could present a low potential of virulence.

Table 1.

Differentially regulated proteins between 258_equi and 1002_ovis

Accession Description 258:1002
Log(2)Ratio(a)
258_equi 1002_ovis Score p_value(a)
Cellular processes and signaling
 Adhesion and motility cell
  I3QUW8_CORPS D9Q5S4_CORP1 Periplasmic zinc binding protein troA 4245,52 -1,32 0
 Cell wall/Membrane and Envelope biogenesis
  I3QYI6_CORPS D9Q3G9_CORP1 Phospho N acetylmuramoyl pentapeptide 166,05 1,22 1
  I3QZH4_CORPS D9Q4F8_CORP1 Corynomycolyl transferase 3886,67 -1,45 0
  I3R044_CORPS D9Q526_CORP1 Peptidoglycan recognition proteino 5283,55 −2,06 0
D9Q4M0_CORP1 Cell wall channel 2220,85 −2,14 0
  I3QYK8_CORPS D9Q3J1_CORP1 Cell wall peptidase NlpC P60 protein 1207,7 −2,78 0
 Defense mechanism
  I3QW82_CORPS D9Q743_CORP1 Cold shock protein 6171,9 1,37 1
  I3R0B7_CORPS D9Q597_CORP1 DNA protection during starvation protein 70,504,73 −1,48 0
  I3QV66_CORPS D9Q632_CORP1 Cold shock protein 31,703,46 −2458 0
  I3QZX1_CORPS D9Q4V4_CORP1 Protein GrpE 57,665,59 −2,64 0
  I3QZW9_CORPS D9Q4V2_CORP1 Heat shock protein HspR 929,96 −3,43 0
 Intracellular trafficking secretion and vesicular transport
  I3QVC7_CORPS D9Q697_CORP1 ABC type transporter 376,36 2,91 1
  I3QZ34_CORPS D9Q431_CORP1 ABC transporter ATP binding protein 6339,11 1,54 1
  I3QZQ5_CORPS D9Q4N9_CORP1 ABC superfamily ATP binding cassette 25,578,26 −1,38 0
  I3R0D8_CORPS D9Q5B9_CORP1 Oligopeptide transport system permease 705,01 −1,45 0,01
 Post-translational modification, protein turnover, chaperones
  I3QWY7_CORPS D9Q7U6_CORP1 Thioredoxin TrxA 1832,12 3,15 1
  I3QVC2_CORPS D9Q692_CORP1 Thiol disulfide isomerase thioredoxin 157,88 1,80 1
  I3QXH3_CORPS D9Q8C5_CORP1 Proteasome accessory factor PafA2 305,06 −1,32 0
  I3QZA4_CORPS D9Q493_CORP1 Glutaredoxin like protein nrdH 3140,61 −1,34 0
  I3QUL7_CORPS D9Q5I3_CORP1 Peptidyl prolyl cis trans isomerase 49,161,11 −1,44 0
  I3QWQ3_CORPS D9Q7L6_CORP1 Ferredoxin 54,332,67 −1,48 0
  I3QW91_CORPS D9Q753_CORP1 Peptidyl prolyl cis trans isomerase 19,736,36 −1,63 0
  I3QV23_CORPS D9Q5Y2_CORP1 Catalase 52,016,22 −1,70 0
  I3QUX7_CORPS D9Q5T5_CORP1 Glyoxalase Bleomycin resistance protein 18,489,51 −1,99 0
  I3QVR1_CORPS D9Q6M3_CORP1 10 kDa chaperonin 90,387,73 −2,78 0
 Signal transduction mechanisms
  I3QY22_CORPS D9Q8W9_CORP1 Phosphocarrier protein HPr 38,569,08 −2,92 0
Information storage and processing
 DNA Metabolism: replication, recombination and repair
  I3QV41_CORPS D9Q606_CORP1 Metallophosphoesterase 529,63 1,88 1
  I3QWM2_CORPS Exodeoxyribonuclease 7 small subunit 10,725,45 −2,00 0
 Transcription: regulation, degradation and RNA processing
  I3QX71_CORPS D9Q817_CORP1 SAM dependent methyltransferase y 397,16 1,25 0,96
  I3QWD6_CORPS D9Q7A0_CORP1 TetR family regulatory protein 5685,08 −1,38 0
  I3QXS5_CORPS D9Q8M5_CORP1 N utilization substance protein B homol 16,977,04 −1,42 0
  I3QWH0_CORPS D9Q7D4_CORP1 Transcriptional regulatory protein PvdS 7456,32 −1,48 0
  I3QYU0_CORPS D9Q3T4_CORP1 Ferric uptake regulatory protein 7805,46 −1,76 0
  I3QWK3_CORPS D9Q7G7_CORP1 Transcription elongation factor GreA 77,246,3 −1,87 0
  I3QZJ2_CORPS D9Q4H4_CORP1 Transcriptional regulator 10,476,01 −1,93 0
  I3QUZ7_CORPS D9Q5V6_CORP1 Nucleoid associated protein ybaB 81,447,09 −3,04 0
  I3QUU4_CORPS D9Q5Q1_CORP1 YaaA protein 25,362,05 −3,14 0
Translation, ribosomal structure and biogenesis
  I3R0I2_CORPS D9Q5F9_CORP1 Ribosomal RNA small subunit methyltrans 395,99 1,29 1
  I3QWD9_CORPS D9Q7A3_CORP1 30S ribosomal protein S14 4756,75 −1,47 0
Metabolism
 Amino acid transport and metabolism
D9Q3B4_CORP1 Glutamate dehydrogenase 1534,86 3,56 1
  I3QXI1_CORPS D9Q8D2_CORP1 Aspartate ammonia lyase 2326,21 1,60 1
  I3QWF9_CORPS D9Q7C4_CORP1 Glycine betaine transporter 136,23 1,21 1
  I3QV21_CORPS D9Q5Y0_CORP1 Aspartate semialdehyde dehydrogenase 8778,47 −1,28 0
  I3QWZ5_CORPS D9Q7V4_CORP1 Cysteine desulfurase 1813,31 −1,31 0
  I3QXT1_CORPS D9Q8N1_CORP1 Chorismate synthase 5341,49 −1,41 0
  I3QXI5_CORPS D9Q8D5_CORP1 Phosphoribosyl ATP pyrophosphatase 25,184,13 −1,90 0
  I3QXL8_CORPS D9Q8G8_CORP1 UPF0237 protein Cp258 1096 16,011,21 −1,96 0
  I3QZZ5_CORPS D9Q4X5_CORP1 Urease subunit beta 4349,97 −2,12 0
 Carbohydrate transport and metabolism
  I3R0E6_CORPS D9Q5C6_CORP1 Aldose 1 epimerase 221,55 2,78 1
  I3QV93_CORPS D9Q660_CORP1 Formate acetyltransferase 1 9381,31 2,00 1
  I3QZB7_CORPS D9Q4A5_CORP1 Phosphoglucomutase 359,43 1,77 1
  I3QWW1_CORPS D9Q7S1_CORP1 L lactate permease 103,53 1,38 0,99
D9Q8W7_CORP1 PTS system fructose specific EIIABC 191,71 1,35 1
  I3QY20_CORPS D9Q8W6_CORP1 1 phosphofructokinase 2879,52 1,32 1
  I3R064_CORPS D9Q545_CORP1 L lactate dehydrogenase 5695,04 1,32 1
  I3R051_CORPS D9Q691_CORP1 Probable phosphoglycerate mutase 2014,4 −1,24 0
D9Q396_CORP1 PTS system fructose specific IIABC 507,53 −1,25 0
  I3QWR8_CORPS D9Q7N1_CORP1 Sucrose 6 phosphate hydrolase 6075,08 −1,34 0
  I3QYN0_CORPS D9Q3L2_CORP1 Glycine cleavage system H proteino 91,529,52 −1,38 0
  I3QWH7_CORPS D9Q7D8_CORP1 Glyceraldehyde 3 phosphate dehydrogenase 9529,4 −2,68 0
 Coenzyme metabolism
D9Q862_CORP1 ATP dependent dethiobiotin synthetase B 104,92 −1,24 1
  I3QUY1_CORPS D9Q5T9_CORP1 Pyridoxal biosynthesis lyase PdxSo 1029,15 −1,42 0
  I3QXF8_CORPS D9Q8B1_CORP1 Precorrin 8X methyl mutase 34,981,98 −1,77 0
  I3QXE1_CORPS D9Q893_CORP1 Hemolysin related protein 3609,76 1,35 0
 Energy metabolism
  I3QUS5_CORPS D9Q5N2_CORP1 NADH dehydrogenase 3257,66 3,14 1
  I3QZ12_CORPS D9Q411_CORP1 Malate dehydrogenase 11,220,59 1,22 1
  I3QXN4_CORPS D9Q8I5_CORP1 Cytochrome oxidase assembly protein 297,19 −1,86 0,09
  I3QYB6_CORPS D9Q3A4_CORP1 Nitrogen regulatory protein P II 16,165,93 −2,29 0
 Inorganic Ion Transport and Metabolism
  I3R097_CORPS D9Q575_CORP1 Cation transport protein 882,31 −4,64 1
  I3QZG5_CORPS D9Q4F0_CORP1 Trk system potassium uptake protein trk 2973,22 1,25 1
  I3QVU4_CORPS D9Q6Q3_CORP1 Hemin binding periplasmic protein hmuT 607,64 1,71 1
  I3QVT3_CORPS D9Q6P2_CORP1 Manganese ABC transporter substrate binding 3917,5 1,51 0
 Lipid transport and metabolism
  I3QUM7_CORPS D9Q5J0_CORP1 Phospholipase D 25,847,67 3,27 1
  I3QZM9_CORPS D9Q4L5_CORP1 Secretory lipase 1254 3,08 1
 Nucleotide metabolism
  I3QZR5_CORPS D9Q4P8_CORP1 Purine phosphoribosyltransferase 227,51 4,45 1
  I3QZF7_CORPS D9Q4E2_CORP1 Phosphoribosylformylglycinamidine synth 978,57 1,45 1
  I3QXV6_CORPS D9Q8Q6_CORP1 Adenine phosphoribosyltransferaseo 907,16 1,44 1
  I3QZ07_CORPS D9Q406_CORP1 Nucleoside diphosphate kinase 14,996,33 1,35 1
  I3QZG8_CORPS D9Q4F3_CORP1 HIT family protein 4039,81 1,21 1
 Secondary metabolites biosynthesis, transport and catabolism
  I3QWA4_CORPS D9Q766_CORP1 Multidrug resistance protein norMo 208,76 1,35 0,98
Poorly characterized
 General function prediction only
  I3QXE6_CORPS D9Q898_CORP1 Methyltransferase type 11 102,29 2,84 0,99
  I3QWH3_CORPS D9Q7D6_CORP1 Enoyl CoA hydratase 225,9 2,14 1
D9Q5M7_CORP1 Unknown function 2201,88 1,93 1
  I3QZJ7_CORPS D9Q4I2_CORP1 Carbonic anhydrase 550,46 1,81 1
  I3QWR6_CORPS D9Q7M9_CORP1 Unknown function 246,05 1,24 0,98
  I3QX38_CORPS Cutinase 11,245,11 −1,48 0
  I3QXY3_CORPS D9Q8T2_CORP1 Chlorite dismutase 32,986,51 −1,51 0
  I3QW56_CORPS D9Q720_CORP1 Methylmalonyl CoA carboxyltransferase 1 4283,03 −1,52 0
  I3QWE6_CORPS D9Q7B0_CORP1 Serine protease 5615,41 −1,54 0
  I3QX14_CORPS D9Q7X2_CORP1 Aldo keto reductase 6121,73 −1,63 0
  I3QWR9_CORPS D9Q7N2_CORP1 Alpha acetolactate decarboxylase 1839,59 −1,73 0
  I3QUU3_CORPS D9Q5Q0_CORP1 UPF0145 protein Cp258 0101 3922,57 −1,77 0
  I3QV73_CORPS D9Q639_CORP1 Hydrolase domain containing protein 5759,37 −2,23 0
  I3QZM7_CORPS D9Q4L2_CORP1 Rhodanese related sulfurtransferase 7428,74 −2,46 0
  I3QYY9_CORPS D9Q3Y7_CORP1 Ankyrin domain containing proteino 11,948,84 −2,84 0
  I3QW24_CORPS D9Q6Y4_CORP1 Hydrolase domain containing protein 15,589,93 −3,04 0
 Unknown function
  I3R0H3_CORPS D9Q5F1_CORP1 Unknown function 7862,73 3,59 1
  I3QX01_CORPS D9Q7W0_CORP1 Unknown function 276,68 3,43 1
  I3QYP3_CORPS D9Q3P0_CORP1 Unknown function 1609,29 2,84 1
  I3QWZ8_CORPS D9Q7V7_CORP1 Unknown function 1476,56 2,58 1
  I3R0H2_CORPS D9Q5F0_CORP1 Unknown function 572,19 1,90 1
  I3QY71_CORPS D9Q919_CORP1 Unknown function 1466,6 1,78 1
  I3QWL3_CORPS D9Q7H7_CORP1 Unknown function 304,96 1,65 0,98
  I3QUW1_CORPS D9Q5R7_CORP1 Unknown function 504,13 1,60 1
  I3QYF2_CORPS D9Q3D7_CORP1 Unknown function 985,97 1,47 1
  I3QWR5_CORPS D9Q7M8_CORP1 Unknown function 103,03 1,45 1
  I3QVG0_CORPS D9Q6C8_CORP1 Unknown function 4085,83 1,39 1
  I3QXI8_CORPS D9Q8D8_CORP1 Unknown function 87,929,25 −1,35 0
  I3QVZ1_CORPS D9Q6U7_CORP1 Unknown function 64,404,7 −1,38 0
  I3R094_CORPS D9Q572_CORP1 Unknown function 4367,05 −1,68 0
  I3QYW4_CORPS D9Q3V8_CORP1 Unknown function 15,928,9 −1,96 0
  I3QUX9_CORPS D9Q5T7_CORP1 Unknown function 8100,51 −2,00 0
  I3QYG8_CORPS D9Q3F3_CORP1 Unknown function 78,035,52 −2,09 0
  I3QUZ5_CORPS D9Q5V4_CORP1 Unknown function 77,763,68 −2,09 0
  I3QUR3_CORPS D9Q5M1_CORP1 Unknown function 12,731,48 −2,27 0
  I3QVV7_CORPS D9Q6R6_CORP1 Unknown function 8564,11 −3,47 0
  I3QXX0_CORPS D9Q8S0_CORP1 Unknown function 19,485,3 −3,50 0
  I3QW02_CORPS D9Q6W1_CORP1 Unknown function 49,581,23 −3,76 0
  I3QVS0_CORPS D9Q6N1_CORP1 Unknown function 66,162,63 −4,87 0
  I3R0G5_CORPS D9Q5E4_CORP1 Unknown function 39,265,48 −5,65 0

The 120 differential proteins were organized by cluster of orthologous groups, and when evaluated the different biological processes that comprise each category listed above, we observed that 19 process were differentials between 258_equi and 1002_ovis (Fig. 2c, Additional file 7: Figure S2 and Additional file 8: Figure S3). The majority of the more abundant proteins (258_equi:1002_ovis) are related to cellular metabolism. On other hand, the majority of the less abundant proteins (258_equi:1002_ovis) are classified as poorly characterized or of unknown function. However, when proteins of known or predicted function are evaluated the majority of the less abundant proteins are related to cellular processes and signaling.

Difference among the major functional classes identified from the core-proteome analysis of 1002_ovis and 258_equi

Metabolism

During the infection process, pathogens need to adjust their metabolism in response to nutrient availability inside and outside the host. In our proteomic study, we identified several proteins related to different metabolic pathways. To determine the metabolic network of each strain, the proteins identified in this study were analyzed using Kyoto Encyclopedia of Genes pathways and Genomes (KEGG) [38]. A total of 321 and 320 proteins, corresponding to 1002_ovis and 258_equi respectively, were mapped onto different metabolic pathways (Additional file 9: Figure S4 and Additional file 10: Figure S5). We observed differences in the metabolism of the biovars, related to Amino acid transport and metabolism, Carbohydrate transport and metabolism, Coenzyme metabolism, Energy metabolism, Lipid transport and metabolism, Nucleotide metabolism and Secondary metabolites biosynthesis, transport and catabolism. Difference in the metabolism cellular, also already were observed in others comparative proteomic study of C. pseudotuberculosis [13, 16, 17, 19], as well as in the Mycobacterium tuberculosis pathogen [39].

Interestingly, the PTS system fructose-specific EIIABC component (PstF) related to carbohydrate metabolism was more abundant in 258_equi, than in 1002_ovis (Table 1). This protein showed increased abundance in field isolates of C. pseudotuberculosis biovar ovis grown in BHI when compared to C231_ovis, a reference strain [19]. This increased abundance of PstF in 258_equi, suggests that this protein could be important to the transport of carbon source both biovar ovis and biovar equi strains. On the other hand, the Precorrin 8X methyl mutase involved in cobalamin and vitamin B12 synthesis can be required only in biovar ovis strains, this protein beside being more abundant in 1002_ovis (Table 1), was also detected with greater abundance in the field isolates of C. pseudotuberculosis biovar ovis after having been grown in BHI [19]. Glutamate dehydrogenase (GDH) was detected more abundant in 258_equi (Table 1). A study performed with the M. bovis pathogen showed that GDH contributes to the survival of this pathogen during macrophage infection [40].

In C. pseudotuberculosis, it was demonstrated that genes related the iron-acquisition are involved in the virulence of this pathogen [41]. In the core-proteome of 1002_ovis and 258_equi, we detected proteins involved in this process, like CiuA, FagC and FagD; however, all these proteins were not differentially regulated between the two strains (Additional file 2: Table S1). On the other hand, HmuT protein, related to hemin uptake, was more abundant in 258_equi (Table 1). Additionally, we have also detected a cell surface hemin receptor in the exclusive proteome of this strain. Heme represents the major reservoir of iron source for many bacterial pathogens that rely on surface-associated heme-uptake receptors [42]. The HmuT is a lipoprotein that acts as a hemin receptor. The hmuT gene is part of the operon hmuTUV, an ABC transport system (haemin transport system), which is normally present in pathogenic Corynebacterium [43, 44]. In addition, in the pathogen C. ulcerans, HmuT is required for normal hemin utilization [44].

Information storage and processing

Of the total protein of proteins identify in the category “information storage and processing” the majority of the differential proteins were less abundant in 258_equi (Table 1). Only, Metallophosphoesterase involved in DNA repair, SAM dependent methyltransferase related to transcriptional process and Ribosomal RNA small subunit methyltransferase I involved in translation process were more induced in 258_equi. In 1002_ovis the Exodeoxyribonuclease 7 important protein related to the DNA-damage pathway was more induced in this strain. In addition, we identified the TetR family regulatory protein as more abundant in 1002_ovis, this result was also observed in field isolates of C. pseudotuberculosis from sheep infected naturally [19]. TerR proteins are related to regulation of multidrug efflux pumps, antibiotic biosynthesis, catabolic process and cellular differentiation process [45]. Others important transcriptional regulators also were induced in 1002_ovis such as PvdS and GreA regulators.

Cellular processes and signaling

Our proteomic analyses detected differentially regulated proteins belonging to different antioxidant systems. These could contribute to the survival of C. pseudotuberculosis in various stress conditions, such as reactive oxygen species (ROS) and reactive nitrogen species (RNS), which are generally found in macrophage. The three major thiol-dependent antioxidant systems in prokaryotic pathogens are the thioredoxin system (Trx), the glutathione system (GSH-system) and the catalase system [46]. Thioredoxin TrxA and Thiol-disulfide isomerase thioredoxin were more abundant in 258_equi (Table 1). These proteins are involved in the Trx-system, which has a major role against oxidative stress [46]. However, proteins like catalase and glutaredoxin (nrdH) were less abundant in 258_equi (Table 1), being more active in 1002_ovis. Catalase plays an important role in resistance to ROS and RNS, as well as in the virulence of M. tuberculosis [47]. The protein NrdH has a glutaredoxin amino acid sequence and thioredoxin activity. It is present in Escherichia coli [48] and C. ammoniagenes [49], as well as in bacteria where the GSH system is absent, such as M. tuberculosis [50]. Thus, the presence of NrdH may represent one more factor that contributes to the resistance of C. pseudotuberculosis against ROS and RNS during the infection process, as well as to the maintenance of the balance of intracellular redox potential. Proteins like NorB and Glyoxalase/Bleomycin, which play roles in the nitrosative stress response of 1002_ovis, were identified in the exclusive proteome of this strain (Additional file 3: Table S2) [14, 18]. These results shown that beside of present proteins with difference in abundance both strains present a set of proteins that could contribute to adaptive process under stress conditions.

Difference proteomic observed in the exclusive proteome of 258_equi and 1002_ovis

We found respectively 105 and 96 proteins in the exclusive proteome of 1002_ovis and 258_equi (Fig. 1) (Additional file 3: Table S2 and Additional file 4: Table S3), related to different biological process (Additional file 7: Figure S2 and Additional file 8: Figure S3). Interestingly, in this exclusive proteome of 1002_ovis and 258_equi, we detected specific proteins in each strain (Table 2, Additional file 3: Table S2 and Additional file 4: Table S3). In the exclusive proteome of 258_equi, the ORFs that codify twenty proteins are annotated as pseudogene in 1002_ovis (Table 2, Additional file 3: Table S2 and Additional file 4: Table S3). On the other hand, the ORFs that encode six proteins were not detected in the genome of 1002_ovis. These proteins are two CRISPR, MoeB, and three unknown function proteins. CRISPR is an important bacterial defense system against infections by viruses or plasmids, this immunity is obtained from the integration of short sequences of invasive DNA ‘spacers’ into the CRISPR loci [51].

Table 2.

Exclusive proteins identified in 258_equi and 1002_ovis

Locus Locus Description Biological Process
1002_ovis
Cp1002_1457 DNA methylaseb DNA Metabolism: replication, recombination and repair
Cp1002_1872 Cp258_1887 Collagen binding surface protein Cnad Adhesion and motility cell
Cp1002_1859 Cp258_1875 Sdr family related adhesind Adhesion and motility cell
Cp1002_2025 Cp258_2050 Glycoside hydrolase 15 related proteind Carbohydrate transport and metabolism
Cp1002_0387 Cp258_0396 Neuraminidase Sialidased Lipid transport and metabolism
Cp1002_0262 Cp258_0266 Ppx/GppA phosphatase familyd General function prediction only
Cp1002_1151 Cp258_1168 Zinc metallopeptidased General function prediction only
Cp1002_0077 Cp258_0091 Unknown functiond Unknown function
258_equi
Cp258_0374 MoeB proteina Coenzyme metabolism
Cp258_1675 CRISPR associated proteina DNA Metabolism: replication, recombination and repair
Cp258_0028 CRISPR-associated proteina DNA Metabolism: replication, recombination and repair
Cp258_0076 Unknown functiona Unknown function
Cp258_0585 Unknown functiona Unknown function
Cp258_0586 Unknown functiona Unknown function
Cp258_0896 Cp1002_0888 Acetolactate synthasec Amino acid transport and metabolism
Cp258_0465 Cp1002_0455 Cystathionine gamma synthasec Amino acid transport and metabolism
Cp258_0313 Cp1002_0310 Aminopeptidase Gc Amino acid transport and metabolism
Cp258_0893 Cp1002_0884 Dihydroxy acid dehydratasec Amino acid transport and metabolism
Cp258_1223 Cp1002_1203 Inositol 1 monophosphatasec Carbohydrate transport and metabolism
Cp258_1360 Cp1002_1337 Unknown functionc Coenzyme metabolism
Cp258_1909 Cp1002_1892 Aldehyde dehydrogenasec Energy metabolism
Cp258_0123 Cp1002_0109 ABC type metal ion transport systemc Inorganic Ion Transport and Metabolism
Cp258_1854 Cp1002_1838 Disulfide bond formation protein DsbBc Post-translational modification, protein turnover, chaperones
Cp258_0395 Cp1002_0386 Methionine aminopeptidasec Post-translational modification, protein turnover, chaperones
Cp258_1923 Cp1002_1906 Oligopeptide binding protein oppAc Intracellular trafficking secretion and vesicular transport
Cp258_1549 Cp1002_1541 ABC transporter ATP binding proteinc Intracellular trafficking secretion and vesicular transport
Cp258_1566 Cp1002_1561 ABC transporterc Intracellular trafficking secretion and vesicular transport
Cp258_0693 Cp1002_0689 Phosphatase YbjIc General function prediction only
Cp258_1503 Cp1002_1497 Alpha beta hydrolasec General function prediction only
Cp258_1265 Cp1002_1243 Unknown functionc General function prediction only
Cp258_0169 Cp1002_0157 NADPH dependent nitro flavin reductasec General function prediction only
Cp258_1351 Cp1002_1329 Unknown functionc Unknown function
Cp258_1916 Cp1002_1899 Unknown functionc Unknown function
Cp258_2099 Cp1002_2077 Unknown functionc Unknown function

(a) Strain-specific protein, ORF detected only in the genome of 258_equi

(b)Strain-specific protein, ORF detected only in the genome of 1002_ovis

(c) ORF predicted like pseudogene in 1002_ovis

(d) ORF predicted like pseudogene in 258_equi

The distinction between the biovar ovis and biovar biovar equi strains is based on a biochemical assay, where biovar ovis strains are negative for nitrate reduction, whereas biovar equi strains are positive [52]. However, to date, there is no available information regarding the molecular basis underlying nitrate reduction in C. pseudotuberculosis biovar equi. MoeB is involved in the molybdenum cofactor (Moco) biosynthesis, which plays an important role in anaerobic respiration in bacteria and also are required to activation of nitrate reductase (NAR) [53]. In the closely related pathogen M. tuberculosis several studies have showed the great importance of molybdenum cofactor in its virulence and pathogenic process, mainly macrophage intracellular environmental [54]. Therefore, more studies are necessary to explore the true role of Moco both physiology and virulence of biovar equi strains. Other protein that also could contribute to resistance of 258_equi macrophage is NADPH dependent nitro/flavin reductase (NfrA), a pseudogene in 1002_ovis. In addition, studies performed in Bacillus subtilis showed that NfrA is involved in both oxidative stress [55] and heat shock resistance [56].

In 1002_ovis, only the ORF that encodes a DNA methylase was not found in the 258_equi genome (Table 2, Additional file 3: Table S2 and Additional file 4: Table S3). In addition, the ORFs that codifies seven proteins identified in the exclusive proteome of the strain 1002_ovis are annotated like pseudogene in 258_equi (Table 2, Additional file 3: Table S2 and Additional file 4: Table S3). Inside this group, we have identified important proteins involved in the process of adhesion and invasion cellular, which might contribute in the pathogenesis of 1002_ovis. Adhesion to host cells is a crucial step that favors the bacterial colonization; this process is mediated by different adhesins [57]. We identified proteins such as: collagen binding surface protein Cna-like and Sdr family related adhesin, which are members of the collagen-binding microbial surface components recognizing adhesive matrix molecules (MSCRAMMs) (Table 2). This class of proteins is present in several Gram positive pathogens and plays an important role in bacterial virulence by acting mainly in the cellular adhesion process [5861].

Another detected protein that might contribute to the virulence of 1002_ovis is Neuraminidase (NanH) (Table 2). This protein belongs to a class of glycosyl hydrolases that contributes to the recognition of sialic acids exposed on host cell surfaces [62]. In C. diphtheriae, it was demonstrated that a protein with trans-sialidase activity promotes cellular invasion [63, 64]. In addition, NanH was reported to be immunoreactive in the immunoproteome of 1002_ovis, showing the antigenicity of this protein [65]. Interestingly, genomic difference in relation to gene involved in the adhesion and invasion process, also already were observed between biovar ovis strain and biovar equi strains, mainly in genes related to pilus [10, 12]. According to pathogenic process of each biovar, unlike biovar equi strains, which rarely causes visceral lesions [4], biovar ovis strains, are responsible mainly by visceral lesions [2, 35], what requires a high ability to adhere and invade the host cell, thus these protein could be responsible by this ability of biovar ovis strain in attacks visceral organs.

Proteogenomic analysis

In our proteomic analysis, the measured MS/MS spectra from the proteomic datasets of 1002_ovis and 258_equi were searched against a concatenated database composed by genome annotation of 1002_ovis CP001809.2 version and 258_equi CP003540.2 version for identify possible errors or unannotated genes. Thus, by adopting more stringent criteria of considering only proteins with a minimum representative of two peptides and a FDR < 1%, we identified five proteins in 1002_ovis and seven proteins in 258_equi, which were not previously annotated. All parameters, as well as, the peptides sequence which were used for identification of these proteins are shown in Additional file 11: Table S6 and Additional file 12: Table S7. The proteins identified in this proteogenomic analysis are associated to different biological processes. For instance, the Aminopeptidase N involved in the amino acid metabolism was detected in 1002_ovis, whereas the Cobaltochelatase (cobN), associated to cobalt metabolism, glutamate dehydrogenase (gdh) involved in the L-glutamate metabolism, the PTS system fructose specific EIIABC related to fructose metabolism and the Phosphoribosylglycinamide formyltransferase involved in the purine biosynthesis were all detected in 258_equi. Proteins involved in DNA processes, such as Uracil DNA glycosylase in 258_equi; and Exodeoxyribonuclease 7 small subunit in 1002_ovis were also detected in both strains. Proteins with general function prediction only and unknown function were also identified in both strains.

Conclusion

In conclusion, we used a label-free quantitative approach to compare, for the first time, the proteome of C. pseudotuberculosis strains belonging to both ovis and equi biovars. Taken together, the findings reported here show a set of shared and exclusive factors of 1002_ovis and 258_equi at the protein level, which can contribute to understanding both the physiology and the virulence of these strains. In addition, the functional analysis of the genome of 1002_ovis and 258_equi allows the in silico validation of data of the genome of these strains. Thus, the proteins identified here may be used as potential new targets for the development of vaccines against ovis and equi C. pseudotuberculosis in future investigations.

Availability of supporting data

The datasets supporting the results of this article were then concatenated into a *xlsx file at peptide and protein level to fulfill the requirements and is available at supplemental material including sequence coverage and a number of identified peptides for each protein sequence identified. It also includes the native peptide information.

Additional files

Additional file 1: Figure S1. (278.8KB, jpg)

Growth rates in BHI media of 1002_ovis (blue circles) and 258_equi (red triangles). (JPEG 278 kb)

Additional file 2: Table S1. (215.8KB, xlsx)

Total list of proteins identified in the core-proteome of 1002_ovis and 258_equi. (XLSX 215 kb)

Additional file 3: Table S2. (21KB, xlsx)

Total list of proteins identified in the exclusive proteome of 1002_ovis. (XLSX 20 kb)

Additional file 4: Table S3. (21.7KB, xlsx)

Total list of proteins identified in the exclusive proteome of 258_equi. (XLSX 21 kb)

Additional file 5: Table S4. (31MB, xlsb)

Total list of peptide and proteins identified 1002_ovis. (XLSB 31769 kb)

Additional file 6: Table S5. (32.4MB, xlsb)

Total list of peptide and proteins identified 258_equi. (XLSB 33204 kb)

Additional file 7: Figure S2. (3.2MB, jpg)

The protein-protein interaction network of 1002_ovis. (A) General interactome of differentially regulated proteins, identified in the exclusive proteome of 1002_ovis. The proteins are marked with different shapes: exclusive proteome, circle; more abundant, square; less abundant, rhombus. The biological processes were marked with different colors: amino acid transport and metabolism, yellow; secondary metabolites biosynthesis, transport and catabolism, aquamarine; inorganic ion transport and metabolism, orange; coenzyme metabolism, brown; carbohydrate transport and metabolism, chartreuse green; nucleotide metabolism, cerulean; energy metabolism, olive; lipid transport and metabolism, viridian; adhesion and motility cell, crimson; iuntracellular trafficking secretion and vesicular transport, persian blue; signal transduction mechanisms, maroon; cell wall/membrane and envelope, gray; defense mechanism, red; post-translational modification, protein turnover, chaperones, electric blue; DNA metabolism, replication, recombination and repair, violet; translation, ribosomal structure and biogenesis, amber; transcription, regulation, degradation and RNA processing, salmon; poorly characterized, white. (JPEG 3310 kb)

Additional file 8: Figure S3. (4.1MB, jpg)

The protein-protein interaction network of 258_equi. (A) General interactome of the differentially regulated proteins, identified in the exclusive proteome of 258_equi. The proteins are marked with different shapes: exclusive proteome, circle; more abundant, square; less abundant, rhombus. The biological processes are marked with different colors: amino acid transport and metabolism, yellow; secondary metabolites biosynthesis, transport and catabolism, aquamarine; inorganic ion transport and metabolism, orange; coenzyme metabolism, brown; carbohydrate transport and metabolism, chartreuse green; nucleotide metabolism, cerulean; energy metabolism, olive; lipid transport and metabolism, viridian; adhesion and motility cell, crimson; intracellular trafficking secretion and vesicular transport, persian blue; signal transduction mechanisms, maroon; cell wall/membrane and envelope, gray; defense mechanism, red; post-translational modification, protein turnover, chaperones, electric blue; DNA metabolism, replication, recombination and repair, violet; translation, ribosomal structure and biogenesis, amber; transcription, regulation, degradation and RNA processing, salmon; poorly characterized, white. (JPEG 4178 kb)

Additional file 9: Figure S4. (8.4MB, jpg)

Metabolic network of 1002_ovis. Red line, proteins identified in the proteomic analysis, other colors represent proteins not identified in this study. (JPEG 8633 kb)

Additional file 10: Figure S5. (1.2MB, jpg)

Metabolic network of 258_equi. Red line, proteins identified in the proteomic analysis, other colors represent proteins not identified in this study. (JPEG 1267 kb)

Additional file 11: Table S6. (216.9KB, xlsx)

Proteins identified in 1002_ovis by Proteogenomics. (XLSX 216 kb)

Additional file 12: Table S7. (266.9KB, xlsx)

Proteins identified in 258_equi by Proteogenomics. (XLSX 266 kb)

Acknowledgment

This work involved the collaboration of various institutions, including the Genomics and Proteomics Network of the State of Pará of the Federal University of Pará, the Amazon Research Foundation (FAPESPA), the National Council for Scientific and Technological Development (CNPq), the Brazilian Federal Agency for the Support and Evaluation of Graduate Education (CAPES), the Minas Gerais Research Foundation (FAPEMIG) and the Waters Corporation, Brazil.

Authors’ contributions

WMS performed microbiological analyses and sample preparation for proteomic analysis. GHMFS and WMS conducted the proteomic analysis. SCS and ELF performed bioinformatics analysis of the data. CSS, AVS, AM and HF contributed substantially to data interpretation and revisions. VA, AS and YLL participated in all steps of the project as coordinators, and critically reviewed the manuscript. All authors read and approved the final manuscript.

Competing interests

The authors declare that they have no competing interests.

Consent for publication

Not applicable.

Ethics approval and consent to participate

No ethics approval was required for any aspect of this study.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Abbreviations

2D-RP

Two-dimensional reversed phase

C

Citosine

FDR

False discovery rate

G

Guanine

HSS

High strength silica

LC/MS

Liquid chromatograph mass spectrometry

nanoESI-HDMS

Nano Electrospray High Definition Mass Spectrometry

nanoUPLC

Nano Ultra Performance Liquid Chromatography

nanoUPLC-MS

Nano Ultra Performance Liquid Chromatography Mass Spectrometry

PBS

Phosphate buffered saline

PLGS

Protein Lynx Global Server

RNS

Reactive nitrogen species

ROS

Reactive oxygen species

Footnotes

Electronic supplementary material

The online version of this article (doi:10.1186/s12864-017-3835-y) contains supplementary material, which is available to authorized users.

Contributor Information

Wanderson M. Silva, Email: silvamarques@yahoo.com.br

Edson L. Folador, Email: edson.folador@gmail.com

Siomar C. Soares, Email: siomars@gmail.com

Gustavo H. M. F. Souza, Email: Gustavosouza@waters.com

Agenor V. Santos, Email: valadaresantos@gmail.com

Cassiana S. Sousa, Email: cassissousa@gmail.com

Henrique Figueiredo, Email: figueiredoh@yahoo.com.

Anderson Miyoshi, Email: miyoshi@icb.ufmg.br.

Yves Le Loir, Email: yves.leloir@rennes.inra.fr.

Artur Silva, Email: asilva@ufpa.br.

Vasco Azevedo, Phone: +55 31 3409 2610, Email: vasco@icb.ufmg.br.

Reference

  • 1.Dorella FA, Pacheco LG, Oliveira SC, Miyoshi A, Azevedo V. Corynebacterium pseudotuberculosis: microbiology, biochemical properties, pathogenesis and molecular studies of virulence. Vet Res. 2006;37:201–218. doi: 10.1051/vetres:2005056. [DOI] [PubMed] [Google Scholar]
  • 2.Baird GJ, Fontaine MC. Corynebacterium pseudotuberculosis and its role in ovine caseous lymphadenitis. J Comp Pathol. 2007;137:179–210. doi: 10.1016/j.jcpa.2007.07.002. [DOI] [PubMed] [Google Scholar]
  • 3.Shpigel NY, Elad D, Yeruham I, Winkler M, Saran A. An outbreak of Corynebacterium pseudotuberculosis infection in an Israeli dairy herd. Vet Rec. 1993;133:89–94. doi: 10.1136/vr.133.4.89. [DOI] [PubMed] [Google Scholar]
  • 4.Britz E, Spier SJ, Kass PH, Edman JM, Foley JE. The relationship between Corynebacterium pseudotuberculosis biovar equi phenotype with location and extent of lesions in horses. Vet J. 2014;200:282–286. doi: 10.1016/j.tvjl.2014.03.009. [DOI] [PubMed] [Google Scholar]
  • 5.Selim SA. Oedematous skin disease of buffalo in Egypt. J Vet Med B Infect Dis Vet Public Health. 2001;48:241–258. doi: 10.1046/j.1439-0450.2001.00451.x. [DOI] [PubMed] [Google Scholar]
  • 6.Paton MW, Walker SB, Rose IR, Watt GF. Prevalence of caseous lymphadenitis and usage of caseous lymphadenitis vaccines in sheep flocks. Aust Vet J. 2002;81:91–95. doi: 10.1111/j.1751-0813.2003.tb11443.x. [DOI] [PubMed] [Google Scholar]
  • 7.Foley JE, Spier SJ, Mihalyi J, Drazenovich N, Leutenegger CM. Molecular epidemiologic features of Corynebacterium pseudotuberculosis isolated from horses. Am J Vet Res. 2004;65:1734–1737. doi: 10.2460/ajvr.2004.65.1734. [DOI] [PubMed] [Google Scholar]
  • 8.Seyffert N, Guimarães AS, Pacheco LG, Portela RW, Bastos BL, Dorella FA, et al. High seroprevalence of caseous lymphadenitis in Brazilian goat herds revealed by Corynebacterium pseudotuberculosis secreted proteins-based ELISA. Res Vet Sci. 2010;88:50–55. doi: 10.1016/j.rvsc.2009.07.002. [DOI] [PubMed] [Google Scholar]
  • 9.Kumar J, Singh F, Tripathi BN. Kumar 454 R, Dixit SK, Sonawane GG. Epidemiological, bacteriological and molecular studies on caseous lymphadenitis in Sirohi goats of Rajasthan, India. Trop Anim Health Prod. 2012;44:1319–1322. doi: 10.1007/s11250-012-0102-8. [DOI] [PubMed] [Google Scholar]
  • 10.Soares SC, Silva A, Trost E, Blom J, Ramos R, Carneiro A, et al. The pan-genome of the animal pathogen Corynebacterium pseudotuberculosis reveals differences in genome plasticity between the biovar ovis and biovar equi strains. PLoS One. 2013;8:e53818. doi: 10.1371/journal.pone.0053818. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Ruiz JC, D’Afonseca V, Silva A, Ali A, Pinto AC, Santos AR, et al. Evidence for reductive genome evolution and lateral acquisition of virulence functions in two Corynebacterium pseudotuberculosis strains. PLoS One. 2011;6:e18551. doi: 10.1371/journal.pone.0018551. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Soares SC, Trost E, Ramos RTJ, Carneiro AR, Santos AR, Pinto AC, et al. Genome sequence of Corynebacterium pseudotuberculosis biovar equi strain 258 and prediction of antigenic targets to improve biotechnological vaccine production. J Biotechnol. 2012;20:135–41. [DOI] [PubMed]
  • 13.Pacheco LG, Slade SE, Seyffert N, Santos AR, Castro TL, Silva WM, et al. A combined approach for comparative exoproteome analysis of Corynebacterium pseudotuberculosis. BMC Microbiol. 2011;17:12. doi: 10.1186/1471-2180-11-12. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Pacheco LG, Castro TL, Carvalho RD, Moraes PM, Dorella FA, Carvalho NB, et al. A Role for Sigma Factor σ(E) in Corynebacterium pseudotuberculosis Resistance to Nitric Oxide/Peroxide Stress. Front Microbiol. 2012;3:126. doi: 10.3389/fmicb.2012.00126. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Silva WM, Seyffert N, Santos AV, Castro TL, Pacheco LG, Santos AR, et al. Identification of 11 new exoproteins in Corynebacterium pseudotuberculosis by comparative analysis of the exoproteome. Microb Pathog. 2013;16:37–42. doi: 10.1016/j.micpath.2013.05.004. [DOI] [PubMed] [Google Scholar]
  • 16.Silva WM, Seyffert N, Ciprandi A, Santos AV, Castro TL, Pacheco LG, et al. Differential Exoproteome analysis of two Corynebacterium pseudotuberculosis biovar ovis strains isolated from goat (1002) and sheep (C231) Curr Microbiol. 2013;67:460–465. doi: 10.1007/s00284-013-0388-4. [DOI] [PubMed] [Google Scholar]
  • 17.Rees MA, Kleifeld O, Crellin PK, Ho B, Stinear TP, Smith AI, et al. Proteomic characterization of a natural host-pathogen interaction: repertoire of in vivo expressed bacterial and host surface-associated proteins. J Proteome Res. 2015;14:120–132. doi: 10.1021/pr5010086. [DOI] [PubMed] [Google Scholar]
  • 18.Silva WM, Carvalho RD, Soares SC, Bastos IF, Folador EL, Souza GH, et al. Label free proteomic analysis to confirm the predicted proteome of Corynebacterium pseudotuberculosis under nitrosative stress mediated by nitric oxide. BMC Genomics. 2014;15:1065. doi: 10.1186/1471-2164-15-1065. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Rees MA, Stinear TP, Goode RJA, Coppel RL, Smith AI, Kleifeld O. Changes in protein abundance are observed in bacterial isolates from a natural host. Front Cell Infect Microbiol. 2015;5:71. doi: 10.3389/fcimb.2015.00071. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72:248–254. doi: 10.1016/0003-2697(76)90527-3. [DOI] [PubMed] [Google Scholar]
  • 21.Silva JC, Gorenstein MV, Li GZ, Vissers JP, Geromanos SJ. Absolute quantification of proteins by LC-MSE: a virtue of parallel MS acquisition. Mol Cell Proteomics. 2006;5:144–156. doi: 10.1074/mcp.M500230-MCP200. [DOI] [PubMed] [Google Scholar]
  • 22.Gilar M, Olivova P, Daly AE, Gebler JC. Two-dimensional separation of peptide using RP-RP-HPLC system with different pH in first and second separation dimensions. J Sep Sci. 2005;28:1694–1703. doi: 10.1002/jssc.200500116. [DOI] [PubMed] [Google Scholar]
  • 23.Silva JC, Denny R, Dorschel CA, Gorenstein M, Kass IJ, Li GZ, et al. Quantitative proteomic analysis by accurate mass retention time pairs. Anal Chem. 2005;1:2187–2200. doi: 10.1021/ac048455k. [DOI] [PubMed] [Google Scholar]
  • 24.Geromanos SJ, Vissers JP, Silva JC, Dorschel CA, Li GZ, Gorenstein MV, et al. The detection, correlation, and comparison of peptide precursor and product ions from data independent LC-MS with data dependant LC-MS/MS. Proteomics. 2009;9:1683–1695. doi: 10.1002/pmic.200800562. [DOI] [PubMed] [Google Scholar]
  • 25.Li GZ, Vissers JP, Silva JC, Golick D, Gorenstein MV, Geromanos SJ. Database searching and accounting of multiplexed precursor and product ion spectra from the data independent analysis of simple and complex peptide mixtures. Proteomics. 2009;9:1696–1719. doi: 10.1002/pmic.200800564. [DOI] [PubMed] [Google Scholar]
  • 26.Levin Y, Hradetzky E, Bahn S. Quantification of proteins using data-independent analysis (MSE) in simple andcomplex samples: a systematic evaluation. Proteomics. 2011;11:3273–3287. doi: 10.1002/pmic.201000661. [DOI] [PubMed] [Google Scholar]
  • 27.Barinov A, Loux V, Hammani A, Nicolas P, Langella P, Ehrlich D, et al. Prediction of surface exposed proteins in Streptococcus pyogenes, with a potential application to other Gram-positive bacteria. Proteomics. 2009;9:61–73. doi: 10.1002/pmic.200800195. [DOI] [PubMed] [Google Scholar]
  • 28.Petersen TN, Brunak S, von Heijne G, Nielsen H. SignalP 4.0: discriminating signal peptides from transmembrane regions. Nat Methods. 2011;8:785–786. doi: 10.1038/nmeth.1701. [DOI] [PubMed] [Google Scholar]
  • 29.Bendtsen JD, Kiemer L, Fausboll A, Brunak S. Non-classical protein secretion in bacteria. BMC Microbiol. 2005;5:58. doi: 10.1186/1471-2180-5-58. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Juncker AS, Willenbrock H, Von Heijne G, Brunak S, Nielsen H, Krogh A. Prediction of lipoprotein signal peptides in Gram-negative bacteria. Protein Sci. 2003;12:1652–1662. doi: 10.1110/ps.0303703. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Conesa A, Gotz S, García-Gómez JM, Terol J, Talón M, Robles M. Blast2GO: a universal tool for annotation, visualization and analysis in functional genomics research. Bioinformatics. 2005;15:3674–3676. doi: 10.1093/bioinformatics/bti610. [DOI] [PubMed] [Google Scholar]
  • 32.Tatusov RL, Natale DA, Garkavtsev IV, Tatusova TA, Shankavaram UT, Rao BS, et al. The COG database: new developments in phylogenetic classification of proteins from complete genomes. Nucleic Acids Res. 2001;29:22–28. doi: 10.1093/nar/29.1.22. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003;13:2498–2504. doi: 10.1101/gr.1239303. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.McKean SC, Davies JK, Moore RJ. Expression of phospholipase D, the major virulence factor of Corynebacterium pseudotuberculosis, is regulated by multiple environmental factors and plays a role in macrophage death. Microbiology. 2007;7:2203–2211. doi: 10.1099/mic.0.2007/005926-0. [DOI] [PubMed] [Google Scholar]
  • 35.Batey RG. Pathogenesis of caseous lymphadenitis in sheep and goats. Aust Vet J. 1986;63:269–272. doi: 10.1111/j.1751-0813.1986.tb08064.x. [DOI] [PubMed] [Google Scholar]
  • 36.Yozwiak ML, Songer JG. Effect of Corynebacterium pseudotuberculosis phospholipase D on viability and chemotactic responses of ovine neutrophils. Am J Vet Res. 1993;54:392–397. [PubMed] [Google Scholar]
  • 37.McNamara PJ, Bradley GA, Songer JG. Targeted mutagenesis of the phospholipase D gene results in decreased virulence of Corynebacterium pseudotuberculosis. Mol Microbiol. 1994;12:921–930. doi: 10.1111/j.1365-2958.1994.tb01080.x. [DOI] [PubMed] [Google Scholar]
  • 38.Kanehisa M, Goto S. KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 2000;28:27–30. doi: 10.1093/nar/28.1.27. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Gunawardena HP, Feltcher ME, Wrobel JA, Gu S, Braunstein M, Chen X. Comparison of the membrane proteome of virulent Mycobacterium tuberculosis and the attenuated Mycobacterium bovis BCG vaccine strain by label-free quantitative proteomics. J Proteome Res. 2013;6:5463–5474. doi: 10.1021/pr400334k. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Gallant JL, Viljoen AJ, van Helden PD, Wiid IJ. Glutamate Dehydrogenase Is Required by Mycobacterium bovis BCG for Resistance to Cellular Stress. PLoS One. 2016;29:e0147706. doi: 10.1371/journal.pone.0147706. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Billington SJ, Esmay PA, Songer JG, Jost BH. Identification and role in virulence of putative iron acquisition genes from Corynebacterium pseudotuberculosis. FEMS Microbiol Lett. 2002;19:41–44. doi: 10.1111/j.1574-6968.2002.tb11058.x. [DOI] [PubMed] [Google Scholar]
  • 42.Contreras H, Chim N, Credali A, Goulding CW. Heme uptake in bacterial pathogens. Curr Opin Chem Biol. 2014;19:34–41. doi: 10.1016/j.cbpa.2013.12.014. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Drazek ES, Hammack AC, Schmitt PM. Corynebacterium diphtheriae genes required for acquisition of iron from hemin and hemoglobin are homologous to ABC hemin transporters. Mol Microbiol. 2000;36:68–84. doi: 10.1046/j.1365-2958.2000.01818.x. [DOI] [PubMed] [Google Scholar]
  • 44.Schmitt MP, Drazek SE. Construction and consequences of directed mutations affecting the hemin receptor in pathogenic Corynebacterium species. J Bacteriol. 2001;183:1476–1481. doi: 10.1128/JB.183.4.1476-1481.2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Ramos JL, Martínez-Bueno M, Molina-Henares AJ, Terán W, Watanabe K, Zhang X, et al. The TetR family of transcriptional repressors. Microbiol Mol Biol Rev. 2005;69:326–356. doi: 10.1128/MMBR.69.2.326-356.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Lu J, Holmgren A. The thioredoxin antioxidant system. Free Radic Biol Med. 2014;8:75–87. doi: 10.1016/j.freeradbiomed.2013.07.036. [DOI] [PubMed] [Google Scholar]
  • 47.Ng VH, Cox JS, Sousa AO, MacMicking JD, McKinney JD. Role of KatG catalase peroxidase in mycobacterial pathogenesis: countering the phagocyte oxidative burst. Mol Microbiol. 2004;52:1291–1302. doi: 10.1111/j.1365-2958.2004.04078.x. [DOI] [PubMed] [Google Scholar]
  • 48.Jordan A, Aslund F, Pontis E, Reichard P, Holmgren A. Characterization of Escherichia coli NrdH. A glutaredoxin-like protein with a thioredoxin-like activity profile. J Biol Chem. 1997;18:18044–18050. doi: 10.1074/jbc.272.29.18044. [DOI] [PubMed] [Google Scholar]
  • 49.Stehr M, Lindqvist Y. NrdH-redoxin of Corynebacterium ammoniagenes forms a domain-swapped dimer. Proteins Struct Funct Bioinform. 2004;55:613–619. doi: 10.1002/prot.20126. [DOI] [PubMed] [Google Scholar]
  • 50.Leiting WU, Jianping XI. Comparative genomics analysis of Mycobacterium NrdH redoxins. Microb Pathog. 2010;48:97–102. doi: 10.1016/j.micpath.2010.01.004. [DOI] [PubMed] [Google Scholar]
  • 51.Jiang W, Marraffini LA. CRISPR-Cas: New Tools for Genetic Manipulations from Bacterial Immunity Systems. Annu Rev Microbiol. 2015;15:209–228. doi: 10.1146/annurev-micro-091014-104441. [DOI] [PubMed] [Google Scholar]
  • 52.Biberstein EL, Knight HD, Jang S. Two biotypes of Corynebacterium pseudotuberculosis. Vet Rec. 1971;25:691–692. doi: 10.1136/vr.89.26.691. [DOI] [PubMed] [Google Scholar]
  • 53.Leimkühler S, Iobbi-Nivol C. Bacterial molybdoenzymes: old enzymes for new purposes. FEMS Microbiol Rev. 2015;13:1–18. doi: 10.1093/femsre/fuv043. [DOI] [PubMed] [Google Scholar]
  • 54.Williams M, Mizrahi V, Kana BD. Molybdenum cofactor: a key component of Mycobacterium tuberculosis pathogenesis? Crit Rev Microbiol. 2014;40:18–29. doi: 10.3109/1040841X.2012.749211. [DOI] [PubMed] [Google Scholar]
  • 55.Mostertz J, Scharf C, Hecker M, Homuth G. Transcriptome and proteome analysis of Bacillus subtilis gene expression in response to superoxide and peroxide stress. Microbiology. 2004;150:497–512. doi: 10.1099/mic.0.26665-0. [DOI] [PubMed] [Google Scholar]
  • 56.Moch C, Schrögel O, Allmansberger R. Transcription of the nfrA-ywcH operon from Bacillus subtilis is specifically induced in response to heat. J Bacteriol. 2000;182:4384–4393. doi: 10.1128/JB.182.16.4384-4393.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.Rogers EA, Das A, Ton-That H. Adhesion by pathogenic corynebacteria. Adv Exp Med Biol. 2011;715:91–103. doi: 10.1007/978-94-007-0940-9_6. [DOI] [PubMed] [Google Scholar]
  • 58.Patti JM, Allen BL, McGavin MJ, Hook M. MSCRAMM-mediated adherence of microorganisms to host tissues. Annu Rev Microbiol. 1994;48:585–617. doi: 10.1146/annurev.mi.48.100194.003101. [DOI] [PubMed] [Google Scholar]
  • 59.Lannergard J, Frykberg L, Guss B. CNE, a collagen-binding protein of Streptococcus equi. FEMS Microbiol Lett. 2003;222:69–74. doi: 10.1016/S0378-1097(03)00222-2. [DOI] [PubMed] [Google Scholar]
  • 60.Nallapareddy SR, Weinstock GM, Murray BE. Clinical isolates of Enterococcus faecium exhibit strain-specific collagen binding mediated by Acm, a new member of the MSCRAMM family. Mol Microbiol. 2003;47:1733–1747. doi: 10.1046/j.1365-2958.2003.03417.x. [DOI] [PubMed] [Google Scholar]
  • 61.Kang M, Ko YP, Liang X, Ross CL, Liu Q, Murray BE, et al. Collagen-binding Microbial Surface Components Recognizing Adhesive Matrix Molecule (MSCRAMM) of Gram-positive Bacteria Inhibit Complement Activation via the Classical Pathway. J Biol Chem. 2013;12:20520–20531. doi: 10.1074/jbc.M113.454462. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 62.Vimr ER, Kalivoda KA, Deszo EL, Steenbergen SM. Diversity of microbial sialic acid metabolism. Microbiol Mol Biol Rev. 2004;68:132–153. doi: 10.1128/MMBR.68.1.132-153.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63.Mattos-Guaraldi AL, Duarte Formiga LC, Pereira GA. Cell surface components and adhesion in Corynebacterium diphtheriae. Microbes Infect. 2000;2:1507–1512. doi: 10.1016/S1286-4579(00)01305-8. [DOI] [PubMed] [Google Scholar]
  • 64.Kim S, Oh DB, Kwon O, Kang HA. Identification and functional characterization of the NanH extracellular sialidase from Corynebacterium diphtheriae. J Biochem. 2010;147:523–533. doi: 10.1093/jb/mvp198. [DOI] [PubMed] [Google Scholar]
  • 65.Seyffert N, Silva RF, Jardin J, Silva WM, Castro TL, Tartaglia NR, et al. Serological proteome analysis of Corynebacterium pseudotuberculosis isolated from different hosts reveals novel candidates for prophylactics to control caseous lymphadenitis. Vet Microbiol. 2014;7:255–260. doi: 10.1016/j.vetmic.2014.08.024. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Additional file 1: Figure S1. (278.8KB, jpg)

Growth rates in BHI media of 1002_ovis (blue circles) and 258_equi (red triangles). (JPEG 278 kb)

Additional file 2: Table S1. (215.8KB, xlsx)

Total list of proteins identified in the core-proteome of 1002_ovis and 258_equi. (XLSX 215 kb)

Additional file 3: Table S2. (21KB, xlsx)

Total list of proteins identified in the exclusive proteome of 1002_ovis. (XLSX 20 kb)

Additional file 4: Table S3. (21.7KB, xlsx)

Total list of proteins identified in the exclusive proteome of 258_equi. (XLSX 21 kb)

Additional file 5: Table S4. (31MB, xlsb)

Total list of peptide and proteins identified 1002_ovis. (XLSB 31769 kb)

Additional file 6: Table S5. (32.4MB, xlsb)

Total list of peptide and proteins identified 258_equi. (XLSB 33204 kb)

Additional file 7: Figure S2. (3.2MB, jpg)

The protein-protein interaction network of 1002_ovis. (A) General interactome of differentially regulated proteins, identified in the exclusive proteome of 1002_ovis. The proteins are marked with different shapes: exclusive proteome, circle; more abundant, square; less abundant, rhombus. The biological processes were marked with different colors: amino acid transport and metabolism, yellow; secondary metabolites biosynthesis, transport and catabolism, aquamarine; inorganic ion transport and metabolism, orange; coenzyme metabolism, brown; carbohydrate transport and metabolism, chartreuse green; nucleotide metabolism, cerulean; energy metabolism, olive; lipid transport and metabolism, viridian; adhesion and motility cell, crimson; iuntracellular trafficking secretion and vesicular transport, persian blue; signal transduction mechanisms, maroon; cell wall/membrane and envelope, gray; defense mechanism, red; post-translational modification, protein turnover, chaperones, electric blue; DNA metabolism, replication, recombination and repair, violet; translation, ribosomal structure and biogenesis, amber; transcription, regulation, degradation and RNA processing, salmon; poorly characterized, white. (JPEG 3310 kb)

Additional file 8: Figure S3. (4.1MB, jpg)

The protein-protein interaction network of 258_equi. (A) General interactome of the differentially regulated proteins, identified in the exclusive proteome of 258_equi. The proteins are marked with different shapes: exclusive proteome, circle; more abundant, square; less abundant, rhombus. The biological processes are marked with different colors: amino acid transport and metabolism, yellow; secondary metabolites biosynthesis, transport and catabolism, aquamarine; inorganic ion transport and metabolism, orange; coenzyme metabolism, brown; carbohydrate transport and metabolism, chartreuse green; nucleotide metabolism, cerulean; energy metabolism, olive; lipid transport and metabolism, viridian; adhesion and motility cell, crimson; intracellular trafficking secretion and vesicular transport, persian blue; signal transduction mechanisms, maroon; cell wall/membrane and envelope, gray; defense mechanism, red; post-translational modification, protein turnover, chaperones, electric blue; DNA metabolism, replication, recombination and repair, violet; translation, ribosomal structure and biogenesis, amber; transcription, regulation, degradation and RNA processing, salmon; poorly characterized, white. (JPEG 4178 kb)

Additional file 9: Figure S4. (8.4MB, jpg)

Metabolic network of 1002_ovis. Red line, proteins identified in the proteomic analysis, other colors represent proteins not identified in this study. (JPEG 8633 kb)

Additional file 10: Figure S5. (1.2MB, jpg)

Metabolic network of 258_equi. Red line, proteins identified in the proteomic analysis, other colors represent proteins not identified in this study. (JPEG 1267 kb)

Additional file 11: Table S6. (216.9KB, xlsx)

Proteins identified in 1002_ovis by Proteogenomics. (XLSX 216 kb)

Additional file 12: Table S7. (266.9KB, xlsx)

Proteins identified in 258_equi by Proteogenomics. (XLSX 266 kb)


Articles from BMC Genomics are provided here courtesy of BMC

RESOURCES